TY  - GEN
AU  - Schachtner,Thomas
AU  - Reinke,Petra
TI  - Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study
SN  - 1399-3062
PY  - 2017///0804
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Allografts
KW  - drug effects
KW  - B-Lymphocytes
KW  - Epstein-Barr Virus Infections
KW  - blood
KW  - Female
KW  - Follow-Up Studies
KW  - Graft Rejection
KW  - epidemiology
KW  - Herpesvirus 4, Human
KW  - Humans
KW  - Immunologic Factors
KW  - administration & dosage
KW  - Kidney Transplantation
KW  - adverse effects
KW  - Lymphoproliferative Disorders
KW  - etiology
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Retrospective Studies
KW  - Rituximab
KW  - Serologic Tests
KW  - Tissue Donors
KW  - Transplant Recipients
KW  - Transplantation Conditioning
KW  - methods
KW  - Viremia
KW  - prevention & control
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1111/tid.12605
ER  -